Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GE.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GE.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GE.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GE.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.11.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.11.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GL.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GL.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.8.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JN.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.6.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.6.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used